Correlations between inflammatory cytokine levels and degree of pigmentation in acral melanomas

Melanoma Res. 2024 Feb 1;34(1):38-43. doi: 10.1097/CMR.0000000000000939. Epub 2023 Nov 2.

Abstract

Cutaneous melanoma, a highly aggressive skin tumor, is characterized by complex signaling pathways in terms of its pathogenesis and progression. Although the degree of pigmentation in melanoma determines its progression, metastasis, and prognosis, its association with inflammatory cytokines remains unclear. Thus, we evaluated the associations between melanoma pigmentation and plasma levels of inflammatory cytokines; furthermore, we investigated the potential variations in this relationship across the primary anatomic sites of melanoma. We enrolled patients with cutaneous melanoma who visited Chonnam National University Hwasun Hospital between January 2021 and December 2021. The anatomical sites of melanoma were categorized as acral and non-acral sites. The degree of pigmentation was quantified using computer software. In total, nine inflammatory cytokines were analyzed, including interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12, IL-13, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-γ (IFN-γ), and tumor necrosis factor-α (TNF-α). This study included 80 melanoma patients. Of these, 53 had acral melanoma and 27 had non-acral melanoma. Overall, plasma concentrations of IL-2, IL-4, IL-5, GM-CSF, and IFN-γ demonstrated significant correlations with diminished pigmentation. Furthermore, in the acral melanoma patients group, plasma concentrations of IL-2, IL-4, IL-5, GM-CSF, IFN-γ, and TNF-α revealed significant correlations with diminished pigmentation. Our results reveal significant associations between melanoma pigmentation and various cytokine levels, particularly in acral melanoma patients; these associations can be influenced by factors related to acral melanoma, such as physical stress or trauma. These correlations may also provide directions for the treatment of acral melanoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Humans
  • Interferon-gamma
  • Interleukin-2
  • Interleukin-4
  • Interleukin-5
  • Melanoma* / pathology
  • Pigmentation
  • Skin Neoplasms* / pathology
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Interleukin-5
  • Interferon-gamma